摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-Benzo[b]thiophen-3-yl-cyclopropylmethyl)-ethyl-amine | 468717-52-4

中文名称
——
中文别名
——
英文名称
(2-Benzo[b]thiophen-3-yl-cyclopropylmethyl)-ethyl-amine
英文别名
N-[[2-(1-benzothiophen-3-yl)cyclopropyl]methyl]ethanamine
(2-Benzo[b]thiophen-3-yl-cyclopropylmethyl)-ethyl-amine化学式
CAS
468717-52-4
化学式
C14H17NS
mdl
——
分子量
231.362
InChiKey
YXILAXWJOWITRA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    40.3
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
    申请人:——
    公开号:US20030073849A1
    公开(公告)日:2003-04-17
    The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts or solvates thereof and pharmaceutically acceptable formulations comprising said compounds 1 useful for the treatment of depression, anxiety disorders, premature ejaculation, chronic pain, obsessive-compulsive disorder, feeding disorders, premenstrual dysphoric disorder, panic disorders and psychotic disorders including bipolar disorder and schizophrenia.
    本发明涉及式(I)的化合物及其药学上可接受的盐或溶剂和包含该化合物的药学上可接受的配方,用于治疗抑郁症、焦虑障碍、早泄、慢性疼痛、强迫症、进食障碍、经前期失调障碍、恐慌障碍以及包括双相情感障碍和精神分裂症在内的精神障碍。
  • [EN] CYCLOPROPYLINDOLE DERIVATIVES AS SELECTIVE SEROTONIN REUPTAKE INHIBITORS<br/>[FR] DERIVES DE CYCLOPROPYLINDOLE UTILISES EN TANT QU'INHIBITEURS SELECTIFS DE RECAPTAGE DE LA SEROTONINE
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2002079152A1
    公开(公告)日:2002-10-10
    The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts or solvates thereof and pharmaceutically acceptable formulaitons comprising said compounds useful for the treatment of depression, anxiety disorders, premature ejaculation, chronic pain, obsessive-compulsive disorder, feeding disorders, premenstrual dysphoric disorder, panic disorders and psychotic disorders including bipolar disorder and schizophrenia.
    本发明涉及式(I)的化合物及其药学上可接受的盐或溶剂,以及包含所述化合物的药学上可接受的制剂,用于治疗抑郁症、焦虑症、早泄、慢性疼痛、强迫症、进食障碍、月经前紧张症、恐慌症和包括双相情感障碍和精神分裂症在内的精神障碍。
  • CYCLOPROPYLINDOLE DERIVATIVES AS SELECTIVE SEROTONIN REUPTAKE INHIBITORS
    申请人:Bristol-Myers Squibb Co.
    公开号:EP1373203A1
    公开(公告)日:2004-01-02
  • US6777437B2
    申请人:——
    公开号:US6777437B2
    公开(公告)日:2004-08-17
  • US6822100B2
    申请人:——
    公开号:US6822100B2
    公开(公告)日:2004-11-23
查看更多

同类化合物

酮替芬EP杂质A 酮替芬 苯噻啶苹果酸盐 苯噻啶盐酸盐 苯噻啶 益托洛替芬 富马酸酮替芬 去甲酮替芬富马酸氢盐 乙基2-[(乙基氨基甲硫杂酰)氨基]-5,6,7,8-四氢-4H-环庚三烯并[b]噻吩-3-羧酸酯 [2,3-d]噻吩并环庚三烯酮 9-氧代酮替芬 9,10-二溴-9,10-二氢-4H-苯并[4,5]环庚并[1,2-b]噻吩-4-酮 9,10-二氧代酮替芬 9, 10-二氢-4H-苯并[4, 5]环庚三烯[1, 2-b]噻吩-4-酮 6H-环庚三烯并[c]噻吩-6-酮,1,3,5,7-四甲基- 5,6,7,8-四氢-4h-环庚基[b]噻吩-2-羧酸 5,6,7,8-四氢-4H-环庚[b]噻吩-2-羧酸酰肼 4H-环庚三烯并[b]噻吩-3-羧酸,5,6,7,8-四氢-2-[3-(羟甲基)-5-甲基-4H-1,2,4-三唑-4-基]-,甲基酯 4-羟基酮替芬 4-(哌啶-4-亚基)-4H-苯并[4,5]环庚三烯并[1,2-B]噻吩-10(9H)-酮 4-(3'-甲基氨基丙基亚基)-9,10-二氢-4H-苯并(4,5)环庚并(1,2-b)噻吩 4,9-二氢-4-(1-甲基-4-哌啶基亚基)-10H-苯并[4,5]环庚三烯并[1,2-b]噻吩-10-酮 N-氧化物; 酮替芬 N-氧化物 2-溴-9,10-二氢-4H-苯并(4,5)环庚并(1,2-b)噻吩-4-酮 2-氯-N-(3-氰基-5,6,7,8-四氢-4H-环戊并[b]噻吩-2-基)-乙酰胺 2-氨基环庚烷并[B]噻吩-3-羧酸乙酯 2-氨基-N-甲基-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-甲酰胺 2-氨基-N-乙基-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-甲酰胺 2-氨基-5,6,7,8-四氢-4H-环庚基[b]噻吩-3-羧酰胺 2-氨基-5,6,7,8-四氢-4H-环庚基[b]噻吩-3-甲腈 2-氨基-5,6,7,8-四氢-4H-环庚[B]噻吩-3-甲酸甲酯 2-乙酰氨基-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-羧酸 2-[(3-氯-1-氧代丙基)氨基]-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-羧酸乙酯 2-(2-氯乙酰基氨基)-5,6,7,8-四氢-4H-环庚[b]噻吩-3-羧酸乙酯 10-甲氧基-4H-苯并[4,5]环庚三烯并[1,2-b]噻吩-4-酮 10-甲氧基-4-(1-甲基-4-哌啶基)-4H-苯并[4,5]环庚三烯并[1,2-B]噻吩-4-醇 1,3-二氢-1-[1-[(5,6,7,8-四氢-4H-环庚[b]噻吩-2-基)羰基]-4-哌啶基]-2H-苯并咪唑-2-酮 (3E)-3-(9,10-二氢-4H-苯并[4,5]环庚三烯并[1,2-b]噻吩-4-亚基)-N,N-二甲基丙烷-1-胺 (+/-)-10-<3-Dimethylamino-propyl>-4,5-dihydro-10H-benzo<5,6>cyclohepta<1,2-b>thiophen-10-ol methyl 2-[3-(acetylamino)-6-methyl-7-oxo-4,5,6,7-tetrahydrobenzo[b]thiophen-6-yl]acetate 10-<3-Dimethylamino-propyliden>-4,5-dihydro-10H-benzo<5,6>-cyclohepta<1,2-b>thiophen ethyl 3-[4-(1-methylpiperidin-4-ylidene)-10-oxo-9,10-dihydro-4H-1-thiabenzo[f]azulen-2-yl]acrylate 2-t-butoxycarbonylamino-4-(1-methylpiperidin-4-ylidene)-9,10-dihydro-4H-1-thiabenzo[f]azulene ethyl 4-[1-(2-ethoxyethyl)piperidin-4-ylidene]-9,10-dihydro-4H-1-thiabenzo[f]azulene-2-carboxylate hydrochloride Ethyl 4-(1-propylpiperidin-4-ylidene)-9,10-dihydro-4H-1-thiabenzo[f]azulene-2-carboxylate hydrochloride 4-(6-chloro-2-methyl-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methyl-piperidine methyl 2-[2-(acetylamino)-6-methyl-7-oxo-4,5,6,7-tetrahydrobenzo[b]thiophen-6-yl]acetate 2-ureidomethyl-4-(1-methylpiperidin-4-ylidene)-9,10-dihydro-4H-1-thiabenzo[f]azulene 2-[2-(9,10-dihydro-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-ethyl]-piperidine-1-carboxylic acid ethyl ester 4-[1-(2-ethoxyethyl)piperidin-4-ylidene]-9,10-dihydro-4H-1-thiabenzo[f]azulene-2-carboxylic acid